Life expectancy after primary treatment for localized prostate cancer is long, so the importance of functional outcomes and quality-of-life measures cannot be underestimated. Careful assessment of the data, with an emphasis on patient selection, definition of clinical significance, and length of follow-up duration, is essential.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Patient-reported functional outcome measures and treatment choice for prostate cancer
BMC Urology Open Access 05 November 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).
Hamdy, F. C. et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N. Engl. J. Med. 375, 1415–1424 (2016).
Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research (National Academies Press, 2009).
Barocas, D. A. et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA 317, 1126–1140 (2017).
Chen, R. C. et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 317, 1141–1150 (2017).
Donovan, J. L. et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N. Engl. J. Med. 375, 1425–1437 (2016).
Resnick, M. J. et al. Long-term functional outcomes after treatment for localized prostate cancer. N. Engl. J. Med. 368, 436–445 (2013).
Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250–1261 (2008).
Mandel, P. et al. High chance of late recovery of urinary and erectile function beyond 12 months after radical prostatectomy. Eur. Urol. 71, 848–850 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Chandrasekar, T., Tilki, D. Comparing quality of life outcomes after prostate cancer treatment. Nat Rev Urol 14, 396–397 (2017). https://doi.org/10.1038/nrurol.2017.81
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.81